Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$100,000.00
Apr 1, 2026
For-profit organization
Key Lipid Process Development, Optimization for Synthesis, and Scale-up
1042257
The project will to develop and optimize a process to synthesize and purify the key lipid components for technology transfer of the process to an accredited Good Manufacturing Practice (GMP) facility.
$545,000.00
Apr 1, 2023
For-profit organization
Delivery system development, characterization, and investigation of bone marrow delivery
1004945
This project will expand the chemistry, manufacturing and controls (CMC) workup of lead formulation materials. This will involve the development of additional quality control measures as well as the expansion of formulation testing and refinement. Additionally, this project aims to demonstrate successful gene editing in the liver.
$375,000.00
Apr 1, 2022
For-profit organization
Neurological, ocular and bone-marrow gene targeting therapy applications
988559
The project will involve the development of expanded Huntington's Disease gene therapy strategies, addition of retinal and bone marrow targeting capabilities, and demonstration of the delivery of alternate gene editing cargos.
$252,000.00
May 1, 2021
For-profit organization
Preclinical Efficacy of Gene Therapy in Brain and Ocular Applications
974365
The proposed project will involve repeat dose testing in a Huntington's Disease model to demonstrate the ability to perform titratable genome editing. Additionally the project will involve proof of concept testing in other organ models of genetic disease.
$10,838.00
Dec 20, 2020
For-profit organization
Innovation Assistance Program – Round 2.5
966053
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
$28,852.00
Jun 25, 2020
For-profit organization
Innovation Assistance Program – Round 2
960894
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
$132,000.00
Jun 1, 2020
For-profit organization
Route of Administration and Preclinical Efficacy of Gene Therapy
952759
This project will involve determining optimal route of administration of Transfection Competent Vesicle (TCV) delivery of gene editing machinery in vivo efficacy studies to generate critical proof of concept data, advance internal drug development and initiate possible pharma partnering opportunities.
$20,328.00
Apr 1, 2020
For-profit organization
Innovation Assistance Program
949456
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
$56,000.00
Jan 2, 2020
For-profit organization
Genetic Delivery and Guide Refinement
940894
This project will involve the delivery of mRNA and selected guiding gene materials (RNAs) to cells in vitro using Transfection competent vesicle (TCV) to evaluate and determine the suitability of TCVs for bench scale delivery of this genetic cargo.
$56,000.00
Apr 1, 2019
For-profit organization
Delivery Technology for Genetic Materials
927145
This project aims to evaluate and determine the effectiveness of a proprietary formulation in the delivery of nucleic acids and gene editing cargo into suspension cell types.